Terbutaline Sulfate Tablet
NDC Package 62559-721-01
Package Information
Terbutaline Sulfate tablets is terbutaline is used to treat wheezing and shortness of breath from lung problems (e.g., asthma, chronic obstructive pulmonary disease-COPD, bronchitis, emphysema). This formulation utilizes a tablet delivery system. Marketed by Ani Pharmaceuticals, Inc., this product is identified by NDC 62559-721 and is authorized under FDA application NDA017849.
Identification & Billing
- RxCUI: 857677 - terbutaline sulfate 2.5 MG Oral Tablet
- RxCUI: 857683 - terbutaline sulfate 5 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 62559 - Ani Pharmaceuticals, Inc.
- 62559-721 - Terbutaline Sulfate
- 62559-721-01 - 100 TABLET in 1 BOTTLE
- 62559-721 - Terbutaline Sulfate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 62559-721-01 identifies a specific commercial package of 100 tablet in 1 bottle of Terbutaline Sulfate, a human prescription drug labeled by Ani Pharmaceuticals, Inc.. This tablet is formulated for oral use and contains terbutaline sulfate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ani Pharmaceuticals, Inc. on October 16, 2018. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Terbutaline is used to treat wheezing and shortness of breath from lung problems (e.g., asthma, chronic obstructive pulmonary disease-COPD, bronchitis, emphysema). Terbutaline belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily.
How is this Ani Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 62559072101. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.